Differential expression of ABC transporters (MDR1, MRP1, BCRP) in developing human embryos

A Konieczna1, B Erdösová, R Lichnovská

  • 1Department of Histology and Embryology, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic. anusia@email.cz

Insights

This study investigated ABC transporters (MDR1, MRP1, BCRP) in human fetal organs. Expression patterns differed in the intestine and liver during intrauterine development, but not in kidneys.

Area of Science:

  • Developmental Biology
  • Molecular Biology
  • Pharmacology

Background:

  • Multidrug resistance (MDR) proteins, including ABC transporters like MDR1, MRP1, and BCRP, are vital for embryogenesis and cancer drug resistance.
  • Understanding their role during human development is crucial for developmental toxicology and pharmacology.

Purpose of the Study:

  • To investigate the organ- and age-specific distribution of MDR1, MRP1, and BCRP during human intrauterine development (IUD).
  • To compare the expression patterns of these ABC transporters in fetal organs with those in adult organs.

Main Methods:

  • Indirect two-step immunohistochemistry was employed.
  • Expression patterns of MDR1, MRP1, and BCRP were analyzed in human embryonal/fetal intestine, liver, and kidneys at various stages of IUD.

Main Results:

  • Significant differences in ABC transporter expression were observed in the intestine and liver during IUD.
  • No age-specific localization of these transporters was found in the kidneys; however, increasing positivity from the surface to deeper, differentiated regions was noted.
  • Expression patterns in fetal organs were compared to adult organ expression.

Conclusions:

  • The study highlights distinct developmental expression profiles for ABC transporters in the human fetal intestine and liver.
  • Kidney expression showed a differentiation-dependent gradient rather than age-specific changes.
  • Findings contribute to understanding the role of MDR pathways in human intrauterine development.

Related Concept Videos

ABC Transporters: Exporter01:31

ABC Transporters: Exporter

ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
ABC Transporters: Importer01:27

ABC Transporters: Importer

ATP-binding cassette or ABC transporters are a class of ATP-driven pumps that hydrolyze ATP to move solutes across the membrane. They can be grouped into importers and exporters. While exporters are present in all domains of life, importers exist only in bacteria and some plants.
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...